Nuwellis (NUWE) Net Margin Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | -3,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,064.00 |
| Dec 31, 2025 | -3,665.00 |
| Sep 30, 2025 | -7,847.00 |
| Jun 30, 2025 | -37,556.00 |
| Mar 31, 2025 | 4,579.00 |
| Dec 31, 2024 | 24,752.00 |
| Sep 30, 2024 | 23,934.00 |
| Jun 30, 2024 | -11,860.00 |
| Mar 31, 2024 | 15,111.00 |
| Dec 31, 2023 | -85,217.00 |
| Sep 30, 2023 | 4,769.00 |
| Jun 30, 2023 | -3,982.00 |
| Mar 31, 2023 | -12,290.00 |
| Dec 31, 2022 | 80,738.00 |
| Sep 30, 2022 | 9,710.00 |
| Jun 30, 2022 | -504.00 |
| Mar 31, 2022 | 3,997.00 |
| Dec 31, 2021 | -11,356.00 |
| Sep 30, 2021 | -6,077.00 |
| Jun 30, 2021 | 2,188.00 |
| Mar 31, 2021 | 803.00 |
| Dec 31, 2020 | 17,357.00 |
| Sep 30, 2020 | 13,640.00 |
| Jun 30, 2020 | 5,364.00 |
| Mar 31, 2020 | 10,881.00 |
| Dec 31, 2019 | -4,205.00 |
| Sep 30, 2019 | -4,899.00 |
| Jun 30, 2019 | 11,627.00 |
| Mar 31, 2019 | 3,081.00 |
| Dec 31, 2018 | 57,384.00 |
| Sep 30, 2018 | -1,366.00 |
| Jun 30, 2018 | -9,595.00 |
| Mar 31, 2018 | -31,554.00 |
| Dec 31, 2017 | -46,889.00 |
| Sep 30, 2017 | 42,387.00 |
| Mar 31, 2015 | -123,898.00 |
| Sep 30, 2014 | -16,441.00 |